Remove Access Remove History Remove Research and Development
article thumbnail

Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research

Cannabis Law Report

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

article thumbnail

Legalization Sparks Boom in Once-Stigmatized Field of Marijuana Research

Puff Puff Post

“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119
article thumbnail

New Research Says Psychedelic Use Is ‘Weakly’ Associated With Symptoms of Psychosis

Veriheal

However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.

article thumbnail

Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application

Cannabis Law Report

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.

article thumbnail

The Evolution of Medical Marijuana: From Stigma to Acceptance in Ohio

MMJ Recs

This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.